Market Wire – AVI BioPharma Opens Investigational New Drug (IND) Application for AVI-4658 in Duchenne Muscular Dystrophy

0

July 7, 2010 — AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based therapeutics, today announced that following review by the U.S. Food and Drug…

More: continued here

Filed under Acne Treatments by on #

Leave a Comment

Fields marked by an asterisk (*) are required.

This blog is protected by Dave\\\\\\\'s Spam Karma 2: 18362 Spams eaten and counting...